André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., . . . Vivier, E. (2018). Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell.
Styl ChicagoAndré, Pascale, et al. "Anti-NKG2A MAb Is a Checkpoint Inhibitor That Promotes Anti-tumor Immunity By Unleashing Both T and NK Cells." Cell 2018.
Citace podle MLAAndré, Pascale, et al. "Anti-NKG2A MAb Is a Checkpoint Inhibitor That Promotes Anti-tumor Immunity By Unleashing Both T and NK Cells." Cell 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..